Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Clinical trial NCT05101213 · TERMINATED

Trial details

NCT number: NCT05101213
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Adenovirus Infection BK Virus Infection Cytomegaloviral Infection Hematopoietic and Lymphoid Cell Neoplasm JC Virus Infection Malignant Solid Neoplasm Symptomatic COVID-19 Infection Laboratory-Confirmed

Start date: 2023-01-06
Primary completion: 2026-08-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.